Pfizer-BioNTech announced Wednesday that its COVID-19 vaccine demonstrated 100% efficacy and robust antibody responses in participants 12 to 15 years of age, Reuters reported.
The companies plan to submit this data to the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) as soon as possible to request expansion of the emergency use authorization.
.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
